Innovate Biopharmaceuticals, Inc. (INNT)

Trade INNT now with
6/24/2019 7:10:02 AM Innovate Biopharma Appoints Ed Sitar As CFO, Commencing On July 1
6/10/2019 8:14:22 AM Innovate Announces Start Of First Phase 3 Clinical Trial In Celiac Disease
12/17/2018 8:25:53 AM Innovate Evaluates Various Funding Proposals For Commencing First Ever Phase 3 Registration Trial For Celiac Disease
11/26/2018 6:03:01 AM Innovate Biopharma: Patrick Griffin Joins As Acting Head Of Clinical Development
10/29/2018 7:06:21 AM Innovate Biopharma Says Positive Effect Of Larazotide Acetate On Reducing Intestinal Permeability In NASH Study
8/23/2018 7:08:54 AM Innovate Agrees With Amarex Clinical Research For Data Management And Biostatistics For Phase 3 Celiac Disease Trial
8/15/2018 7:12:36 AM Innovate Biopharma Q2 Net Loss $4.2 Mln Or $0.16/Shr Vs Loss Of $2.8 Mln Or $0.23/Shr Last Year
6/28/2018 7:14:11 AM Innovate To Collaborate With Professor Colin Stine At The University Of Maryland School Of Medicine